Peptide Therapeutics Market is expected to fuel the market growth over the forecast period

Short chains of amino acid monomers which are linked by amide bonds are termed as peptides. Peptides are different from proteins due to difference in their sizes. Peptides contain less than 50 molecules of amino acids. Peptides bind themselves to some specific cell surface receptors and imitate like receptor ligands. This characteristic of peptides helps in treating various diseases as peptides act on the cell membrane. Increasing number of cancer patients and various metabolic diseases as well as technological advancements such as introduction of hybrid method of synthesis of peptides, are expected to drive the peptide therapeutics market over the forecast period. Huge market potential has been identified in peptide therapeutics market globally and thus various pharmaceutical and biotechnology industries are actively investing in research & development activities to develop newer peptides to be used for various applications. Cancer has been a major cause of death globally. According to world health organisation (WHO), number of cancer patients is expected to increase from 12.7 million per year in 2011 to 16 million per year in 2020.

Increase in metabolic diseases such as diabetes, along with increase in number of cancer patients is expected to boost the market for peptide therapeutics. Continuous R&D in peptide therapeutics has developed various technologies and routes of administration of peptides. However, the conventional route of administration which is parenteral route has grabbed maximum share in terms of revenue of total market share of peptides by route of administration in 2013. Technology market was dominated by long phase peptide synthesis (SPSS) of total market share in 2013. Peptide therapeutics market can be classifies on the basis of technology used, application, route of administration and product of peptides. North America holds largest market share while Asia Pacific region is expected to grow at a significant rate over next six years. Key market participants for this market include Roche, Novo-Nordisk, Bachem, Lonza, Eli Lilly, Amylin, Ipsen, Polypeptide Group, Peptisyntha etc.

Key technology segments analysed in this report include solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS) and hybrid phase peptide synthesis (HPSS). SPSS technology segment dominated the overall peptide therapeutics market in terms of revenue in 2013. Due to introduction of newer technologies like HPSS, market share of SPSS is expected to reduce by 2020. HPSS is the fastest growing technological segment over the forecast period.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market

Key applications of peptide therapeutics reviewed in this report include cancer, metabolic, cardiovascular, dermatology, anti-infection, gastro intestinal, renal, respiratory, pain and others. Use of Peptide Therapeutics for treatment of cancer has captured most of the market share of total ablation market in 2013. Increase in numbers of cancer patients has driven the market growth. Increasing awareness about Peptide Therapeutics for treatment of cancer is expected to fuel the market to grow. Use of Peptide Therapeutics for treatment of cancer was followed by metabolicapplications. 

Key routes of administration of peptide therapeutics analysed in this report include parenteral route, oral route, pulmonary route, mucosal route and other routes such as intradermal route & nasal route. Traditional route of administration, parenteral route has captured most of the market share as it has been used for a long time. Higher comfort level of patients with parenteral route is expected to fuel the market growth over the forecast period.

This report analyses the peptide therapeutics market by products of peptides as innovative and generic. Innovative peptides dominated the total market share in 2013 in terms of revenue owing to their higher prices than the generic peptides. Technological advancement is also expected to fuel the growth of innovative product segment during the forecast period.

North America holds maximum market share of total peptide therapeutics market in terms of revenue in 2013. North America was followed by Europe. Higher awareness about medication and available treatments has helped this market to grow in North America and Europe. Economic recession has affected the market growth on these regions negatively. Asia Pacific region has observed a significant growth rate over last two years and is expected to grow at the same rate over the forecast period owing to increasing disposable income of patients. Developing economies like India and China are expected to fuel the market growth over the forecast period. Peptide therapeutics market is expected to grow at a relatively sluggish rate in Europe and North America.

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com